Physical activity and fatigue in CML patients
Recruiting
- Conditions
- CML, chronic myeloid leukemia, chronische myeloide leukemie
- Registration Number
- NL-OMON23388
- Lead Sponsor
- Radboud UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
CML patients
> = 18 years
Exclusion Criteria
< 18 years
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Steps per day, stepping time
- Secondary Outcome Measures
Name Time Method Sitting time
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link physical activity to fatigue reduction in CML patients on TKI therapy?
How does TKI therapy impact physical activity levels and fatigue in CML compared to standard-of-care treatments?
Are there specific biomarkers that correlate with physical activity and fatigue outcomes in CML patients undergoing TKI therapy?
What are the potential adverse events associated with increased physical activity in CML patients on TKI therapy and how can they be managed?
How do combination approaches involving TKI therapy and physical activity interventions compare to other treatment strategies in managing CML-related fatigue?